Strategic Partnerships MedTech Innovator runs the world's largest medical technology accelerator and is actively forming partnerships with industry players (e.g., Sequenex) to support startups, suggesting opportunities to collaborate on co-hosted programs, joint ventures, or sponsored acceleration tracks that can connect portfolio companies with your sales channels.

Regulatory Access An advisor with former CDRH leadership is joining MTI, signaling deep regulatory and global market access expertise within MTI’s ecosystem. This presents a sales angle to offer regulatory strategy services, compliance tooling, and market access packages to portfolio companies expanding internationally.

Portfolio Activation MTI launched the MTI Index to make its 65-company portfolio permanently discoverable to investors, health systems, and media. This creates a pipeline-ready channel for enterprise buyers and investors to identify and engage with MTI-aligned solutions, presenting a ready-made lead source for B2B sales teams.

Award and Recognition Recent award announcements (e.g., 2026 Vision Award, 2025 Grand Prizes) highlight credible validation within the medtech community. This can be leveraged to approach MTI portfolio companies and conference participants as trusted vendors or strategic technology partners seeking endorsement and collaboration.

Funding and Scale With MTI revenue in the mid-range and a high-visibility accelerator program attracting a wide cohort, there are clear opportunities to offer scalable sales enablement, CRM/marketing automation services, and enterprise deployment packages tailored to rapid-growth medical device and digital health startups preparing for Series A/Series B and healthcare system deployments.